福建省中医药研究院/福建省中医睡眠医学重点实验室
纸质出版:2018
移动端阅览
[1]曾雪爱,周春权,王秀峰,张瑜,张一帆,黄俊山.左归丸、右归丸对失眠和多睡模型大鼠血浆中单胺类神经递质的影响[J].中医杂志,2018,59(07):612-616.
ZENG Xueai, ZHOU Chunquan, WANG Xiufeng, et al. Impact of Zuogui Wan(左归丸) and Yougui Wan(右归丸) on Plasma Monoamine Neurotransmitter in Insomnia and Sleepiness Model Rats’[J]. Journal of Traditional Chinese Medicine2018, 59(7): 612-616.
[1]曾雪爱,周春权,王秀峰,张瑜,张一帆,黄俊山.左归丸、右归丸对失眠和多睡模型大鼠血浆中单胺类神经递质的影响[J].中医杂志,2018,59(07):612-616. DOI: 10.13288/j.11-2166/r.2018.07.018.
ZENG Xueai, ZHOU Chunquan, WANG Xiufeng, et al. Impact of Zuogui Wan(左归丸) and Yougui Wan(右归丸) on Plasma Monoamine Neurotransmitter in Insomnia and Sleepiness Model Rats’[J]. Journal of Traditional Chinese Medicine2018, 59(7): 612-616. DOI: 10.13288/j.11-2166/r.2018.07.018.
目的探讨左归丸、右归丸改善睡眠失衡状态的可能作用机制。方法 25只SD大鼠随机分为正常对照组、失眠模型组、多睡模型组、左归丸组、右归丸组
每组5只。失眠模型组和左归丸组大鼠给予中缝背核内微量注射1A型5-羟色胺(5-HT1A)受体阻断剂WAY 100635建立失眠模型
多睡模型组和右归丸模型组大鼠微量注射5-HT1A受体激动剂8-OH-DPAT建立多睡模型
正常对照组中缝背核微量注射等量的生理盐水
连续3天。于末次注射2h后左归丸组大鼠给予左归丸溶液17.5 g/(kg·d)灌胃
右归丸组给予右归丸溶液18.5 g/(kg·d)灌胃
其余3组大鼠给予10 ml/(kg·d)蒸馏水灌胃
每天1次
共7天。采用高效液相谱法检测各组大鼠血浆中单胺类神经递质多巴胺(DA)、二羟基苯乙酸(DOPAC)、5-羟色胺(5-HT)、5-羟吲哚乙酸(5-HIAA)的含量
并计算5-HIAA/5-HT。结果与正常对照组比较
失眠模型组大鼠血浆DA、DOPAC、5-HIAA含量及5-HIAA/5-HT升高(P<0.01);多睡模型组大鼠血浆DA、DOPAC、5-HIAA含量及5-HIAA/5-HT降低(P<0.05或P<0.01)。与失眠模型组比较
左归丸组大鼠血浆DA、DOPAC、5-HIAA含量及5-HIAA/5-HT均降低(P<0.05或P<0.01);与多睡模型组比较
右归丸组大鼠血浆DA、DOPAC、5-HIAA含量及5-HIAA/5-HT升高(P<0.05)。各组大鼠血浆5-HT含量差异均无统计学意义(P>0.05)。结论左归丸能有效降低失眠大鼠兴奋性神经递质
右归丸能有效升高多睡大鼠兴奋性神经递质
二者可能通过平衡神经递质改善睡眠失衡状态。
Objective To explore the potential mechanism of Zuogui Wan(左归丸) and Yougui Wan(右归丸) in improving sleep imbalance. Methods Twenty-five Sprague Dawley(SD) rats were randomized into the normal control group
the insomnia model group
the sleepiness model group
the Zuogui Wan group and the Yougui Wan group
with 5 rats in each group. Rats in the insomnia model group and the Zuogui Wan group were made insomnia models by type 1 A 5-hydroxytryptamine(5-HT1 A) receptor blocker WAY 100635 microinjection into dorsal raphe nucleus. Rats in the sleepiness model group and the Yougui Wan group were made sleepiness models by 5-HT1 A receptor agonist 8-OH-DPAT microinjection. The normal control group was given equivalent normal saline microinjection into dorsal raphe nucleus
for 3 days. Two hours after the last injection
rats in the Zuogui Wan group was given Zuogui Wan solution 17. 5 g/(kg · d) by gavage. The Yougui Wan group was given Yougui Wan solution 18. 5 g/(kg·d) by gavage. Rats in the other 3 groups were given 10 ml/(kg·d) distilled water by gavage
once every day
for 7 days. The levels of monoamine neurotransmitter dopamine(DA)
dihydroxyphenylacetic acid(DOPAC)
5-hydroxytryptamine(5-HT) and 5-hydroxyindoleacetic acid(5-HIAA) in rats’ plasma in each group were determined by high performance liquid spectrum method; 5-HIAA/5-HT was calculated. Results Compared with the normal control group
the levels of plasma DA
DOPAC and 5-HIAA as well as 5-HIAA/5-HT in the insomnia model group increased(P < 0. 01); while those in the sleepiness model group decreased(P < 0. 05 or P < 0. 01). Compared with the insomnia model group
the levels of DA
DOPAC and 5-HIAA as well as 5-HIAA/5-HT in the Zuogui Wan group decreased(P < 0. 05 or P < 0. 01). Compared with the sleepiness model group
the levels of DA
DOPAC and5-HIAA as well as 5-HIAA/5-HT in the Yougui Wan group increased(P < 0. 01). The difference of 5-HT level in rats’ plasma in each group was not significant(P > 0. 05). Conclusion Zuogui Wan might reduce the excitatory neurotransmitters in insomnia rats
while Yougui Wan might increase the excitatory neurotransmitters in sleepiness rats. Both might improve sleep imbalance by balancing neurotransmitters.
0
浏览量
300
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号